Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metamorphosis, Biological | 2 | 2009 | 15 | 0.580 |
Why?
|
| Triiodothyronine | 2 | 2009 | 30 | 0.570 |
Why?
|
| Blood Platelets | 3 | 2020 | 74 | 0.500 |
Why?
|
| Neuromuscular Junction | 5 | 2006 | 33 | 0.470 |
Why?
|
| Rana catesbeiana | 3 | 2009 | 27 | 0.450 |
Why?
|
| Receptors, Nicotinic | 7 | 2007 | 91 | 0.400 |
Why?
|
| Locomotion | 2 | 2014 | 91 | 0.360 |
Why?
|
| Swimming | 1 | 2009 | 37 | 0.340 |
Why?
|
| Thyrotropin | 1 | 2008 | 15 | 0.320 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2008 | 41 | 0.320 |
Why?
|
| Menopause | 1 | 2008 | 54 | 0.310 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 881 | 0.310 |
Why?
|
| Tryptophan | 5 | 2004 | 62 | 0.280 |
Why?
|
| Tail | 2 | 2003 | 5 | 0.260 |
Why?
|
| Potassium Channels | 2 | 1999 | 73 | 0.250 |
Why?
|
| Receptors, Cholinergic | 4 | 2004 | 28 | 0.240 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2003 | 1 | 0.230 |
Why?
|
| Torpedo | 7 | 2004 | 41 | 0.230 |
Why?
|
| Choroid | 1 | 2022 | 10 | 0.220 |
Why?
|
| Vertebrates | 1 | 2022 | 29 | 0.210 |
Why?
|
| Amino Acid Substitution | 6 | 2006 | 122 | 0.210 |
Why?
|
| Patch-Clamp Techniques | 9 | 2014 | 214 | 0.210 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2019 | 95 | 0.210 |
Why?
|
| Animals | 22 | 2022 | 14307 | 0.190 |
Why?
|
| Amyloidosis | 1 | 2020 | 33 | 0.190 |
Why?
|
| Parkinson Disease | 1 | 2020 | 167 | 0.170 |
Why?
|
| Acetylcholine | 5 | 2006 | 68 | 0.170 |
Why?
|
| Neuroglia | 1 | 1999 | 117 | 0.160 |
Why?
|
| Glaucoma | 1 | 2019 | 87 | 0.160 |
Why?
|
| Oocytes | 8 | 2007 | 143 | 0.150 |
Why?
|
| Chemical Phenomena | 1 | 2016 | 53 | 0.140 |
Why?
|
| Hemeproteins | 1 | 2016 | 13 | 0.140 |
Why?
|
| Retina | 1 | 1999 | 255 | 0.140 |
Why?
|
| Magnetics | 1 | 2016 | 36 | 0.140 |
Why?
|
| Muscles | 2 | 1988 | 64 | 0.140 |
Why?
|
| Membrane Potentials | 5 | 2003 | 213 | 0.140 |
Why?
|
| Bufo marinus | 3 | 1991 | 6 | 0.140 |
Why?
|
| Brain | 2 | 2020 | 1268 | 0.140 |
Why?
|
| Protein Subunits | 3 | 2004 | 85 | 0.140 |
Why?
|
| Quinine | 1 | 2014 | 10 | 0.130 |
Why?
|
| Ion Channels | 3 | 2006 | 69 | 0.130 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.130 |
Why?
|
| Membrane Lipids | 2 | 2007 | 31 | 0.130 |
Why?
|
| Ventral Tegmental Area | 1 | 2014 | 36 | 0.130 |
Why?
|
| Myasthenic Syndromes, Congenital | 2 | 2006 | 4 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 70 | 0.120 |
Why?
|
| Ion Channel Gating | 3 | 2004 | 81 | 0.120 |
Why?
|
| Behavior, Animal | 1 | 2014 | 304 | 0.110 |
Why?
|
| Cocaine | 1 | 2014 | 219 | 0.110 |
Why?
|
| Xenopus laevis | 7 | 2007 | 73 | 0.110 |
Why?
|
| Mutation | 3 | 2006 | 1023 | 0.100 |
Why?
|
| Larva | 2 | 2003 | 117 | 0.100 |
Why?
|
| Synaptic Transmission | 2 | 2006 | 141 | 0.090 |
Why?
|
| Synapses | 1 | 1991 | 173 | 0.090 |
Why?
|
| Cheek | 1 | 2009 | 14 | 0.090 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 17 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2004 | 168 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 6 | 2007 | 383 | 0.080 |
Why?
|
| Kinetics | 4 | 2006 | 650 | 0.080 |
Why?
|
| Muscle Proteins | 1 | 2007 | 48 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2008 | 429 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 286 | 0.070 |
Why?
|
| Potassium Compounds | 1 | 1984 | 4 | 0.060 |
Why?
|
| Fluorides | 1 | 1984 | 19 | 0.060 |
Why?
|
| Bungarotoxins | 4 | 2007 | 21 | 0.060 |
Why?
|
| Sodium | 1 | 1984 | 101 | 0.060 |
Why?
|
| Xenopus | 4 | 2004 | 44 | 0.060 |
Why?
|
| Niflumic Acid | 1 | 2003 | 1 | 0.060 |
Why?
|
| Chloride Channels | 1 | 2003 | 2 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2003 | 33 | 0.060 |
Why?
|
| Puerto Rico | 1 | 2008 | 1352 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 57 | 0.060 |
Why?
|
| Muscle Weakness | 1 | 2002 | 7 | 0.050 |
Why?
|
| Humans | 8 | 2020 | 34853 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 490 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2022 | 186 | 0.050 |
Why?
|
| Nicotine | 1 | 2004 | 238 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 2333 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2001 | 109 | 0.050 |
Why?
|
| Cholesterol | 1 | 2001 | 194 | 0.050 |
Why?
|
| Calcium | 1 | 2003 | 445 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 1124 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2020 | 103 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1490 | 0.040 |
Why?
|
| Neural Conduction | 1 | 1999 | 19 | 0.040 |
Why?
|
| Aged | 2 | 2008 | 6448 | 0.040 |
Why?
|
| Neurons | 1 | 2004 | 1130 | 0.040 |
Why?
|
| Gene Expression | 3 | 2007 | 639 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1300 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 275 | 0.030 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 4 | 0.030 |
Why?
|
| Prazosin | 1 | 2014 | 11 | 0.030 |
Why?
|
| Benzophenanthridines | 1 | 2014 | 9 | 0.030 |
Why?
|
| Adrenergic Agents | 1 | 2014 | 8 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 45 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 10 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 32 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 30 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 34 | 0.030 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 21 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 171 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2014 | 177 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 52 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 117 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2004 | 172 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2014 | 110 | 0.030 |
Why?
|
| Male | 5 | 2014 | 18870 | 0.030 |
Why?
|
| Middle Aged | 1 | 2008 | 9642 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 249 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2001 | 751 | 0.030 |
Why?
|
| Indoles | 1 | 2014 | 154 | 0.030 |
Why?
|
| Dopamine | 1 | 2014 | 232 | 0.030 |
Why?
|
| Electric Conductivity | 2 | 2000 | 47 | 0.030 |
Why?
|
| Adult | 1 | 2008 | 11034 | 0.030 |
Why?
|
| Binding Sites | 2 | 2004 | 597 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2003 | 350 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2004 | 360 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1991 | 138 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1534 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 5668 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 984 | 0.020 |
Why?
|
| Pedigree | 1 | 2006 | 64 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 49 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 75 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2006 | 95 | 0.020 |
Why?
|
| Cesium | 1 | 1984 | 7 | 0.020 |
Why?
|
| Microinjections | 1 | 2004 | 55 | 0.020 |
Why?
|
| Permeability | 1 | 1984 | 67 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 257 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2003 | 61 | 0.020 |
Why?
|
| Potassium | 1 | 1984 | 110 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2003 | 87 | 0.010 |
Why?
|
| Motor Endplate | 1 | 2002 | 3 | 0.010 |
Why?
|
| Electromyography | 1 | 2002 | 49 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 88 | 0.010 |
Why?
|
| Molecular Probes | 1 | 2001 | 23 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 913 | 0.010 |
Why?
|
| Allosteric Site | 1 | 2000 | 11 | 0.010 |
Why?
|
| Time Factors | 1 | 1984 | 1681 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 376 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 968 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3261 | 0.010 |
Why?
|
| Child | 1 | 2002 | 2875 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 5035 | 0.010 |
Why?
|
| Female | 1 | 2006 | 19873 | 0.000 |
Why?
|